Browse
Browse
Home
People
Organizations
Research
Events
Capability Map
A Phase II of Rituximab in Myasthenia Gravis (NN 103)
Grant
Overview
Affiliation
Overview
Awarded By
MASSACHUSETTS GENERAL HOSPITAL
Total Award Amount
16536.00
Direct Costs
11249.00
Sponsor Award Id
Affiliation
Contributor
Eroboghene Ubogu
Investigator